open access

Vol 24, No 2 (2020)
ORIGINAL PAPERS
Published online: 2019-11-20
Get Citation

Effect of achieving blood pressure targets on the relative telomere length in hypertensive patients with and without type 2 diabetes mellitus

Valeriya Nemtsova, Tetiana Bondar, Anna Shalimova
DOI: 10.5603/AH.a2019.0016
·
Arterial Hypertension 2020;24(2):61-66.

open access

Vol 24, No 2 (2020)
ORIGINAL PAPERS
Published online: 2019-11-20

Abstract

Background. The role of relative telomere length (RTL) as a marker of cardiovascular prognosis and quality control
of the disease course remains to be found out. The aim of the study was to determine the relationship between
the relative blood leukocyte telomere length (RLTL), relative buccal epithelium cell telomere length (RBTL) and
achieving blood pressure targets (BPTs) in hypertensive (H) individuals with type 2 diabetes mellitus (T2DM) and
without T2DM.

Material and methods. In 156 patients with stage II hypertension (96 of them had T2DM), carbohydrate metabolism
parameters and blood pressure levels were evaluated. RLTL and RBTL were determined by a real time
quantitative PCR.

Results. A combination of hypertension and T2DM was associated with significantly greater RLTL (p = 0.009) and
RBTL (p = 0.001) compared with isolated hypertension. There was no convincing evidence of BPT influence on
the change in the RLTL in isolated hypertension. Achieving BP targets was associated with a paradoxical shortening
of RBTL. There was a significant shortening of RTL in hypertensive patients with T2DM when the BPTs were not
reached. An analysis of variance revealed a significant influence of BPTs on the RBTL and RLTL.

Conclusion. Patients with a comorbid course of hypertension and T2DM had more pronounced decrease in the
RTL. Target levels of blood pressure have a more significant effect on the RLT than the glycemic control in patients
with concomitant T2DM. An additional determination of the RBTL enhances the diagnostic and prognostic power
when evaluating the effectiveness of correcting cardiovascular risk factors including blood pressure.

Abstract

Background. The role of relative telomere length (RTL) as a marker of cardiovascular prognosis and quality control
of the disease course remains to be found out. The aim of the study was to determine the relationship between
the relative blood leukocyte telomere length (RLTL), relative buccal epithelium cell telomere length (RBTL) and
achieving blood pressure targets (BPTs) in hypertensive (H) individuals with type 2 diabetes mellitus (T2DM) and
without T2DM.

Material and methods. In 156 patients with stage II hypertension (96 of them had T2DM), carbohydrate metabolism
parameters and blood pressure levels were evaluated. RLTL and RBTL were determined by a real time
quantitative PCR.

Results. A combination of hypertension and T2DM was associated with significantly greater RLTL (p = 0.009) and
RBTL (p = 0.001) compared with isolated hypertension. There was no convincing evidence of BPT influence on
the change in the RLTL in isolated hypertension. Achieving BP targets was associated with a paradoxical shortening
of RBTL. There was a significant shortening of RTL in hypertensive patients with T2DM when the BPTs were not
reached. An analysis of variance revealed a significant influence of BPTs on the RBTL and RLTL.

Conclusion. Patients with a comorbid course of hypertension and T2DM had more pronounced decrease in the
RTL. Target levels of blood pressure have a more significant effect on the RLT than the glycemic control in patients
with concomitant T2DM. An additional determination of the RBTL enhances the diagnostic and prognostic power
when evaluating the effectiveness of correcting cardiovascular risk factors including blood pressure.

Get Citation

Keywords

hypertension; type 2 diabetes mellitus; relative telomere length; cardiovascular risk factors

About this article
Title

Effect of achieving blood pressure targets on the relative telomere length in hypertensive patients with and without type 2 diabetes mellitus

Journal

Arterial Hypertension

Issue

Vol 24, No 2 (2020)

Pages

61-66

Published online

2019-11-20

DOI

10.5603/AH.a2019.0016

Bibliographic record

Arterial Hypertension 2020;24(2):61-66.

Keywords

hypertension
type 2 diabetes mellitus
relative telomere length
cardiovascular risk factors

Authors

Valeriya Nemtsova
Tetiana Bondar
Anna Shalimova

References (19)
  1. Rizvi S, Raza ST, Mahdi F. Telomere length variations in aging and age-related diseases. Curr Aging Sci. 2014; 7(3): 161–167.
  2. Bhupatiraju C, Saini D, Patkar S, et al. Association of shorter telomere length with essential hypertension in Indian population. Am J Hum Biol. 2012; 24(4): 573–578.
  3. Arsenis NC, You T, Ogawa EF, et al. Physical activity and telomere length: Impact of aging and potential mechanisms of action. Oncotarget. 2017; 8(27): 45008–45019.
  4. Harte AL, da Silva NF, Miller MA, et al. Telomere length attrition, a marker of biological senescence, is inversely correlated with triglycerides and cholesterol in South Asian males with type 2 diabetes mellitus. Exp Diabetes Res. 2012; 2012: 895185.
  5. Ma D, Zhu W, Hu S, et al. Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients. J Endocrinol Invest. 2013; 36(11): 1032–1037.
  6. Yang Z, Huang X, Jiang H, et al. Short telomeres and prognosis of hypertension in a chinese population. Hypertension. 2009; 53(4): 639–645.
  7. Fyhrquist F, Saijonmaa O, Strandberg T. The roles of senescence and telomere shortening in cardiovascular disease. Nat Rev Cardiol. 2013; 10(5): 274–283.
  8. Kolyada AK, Vayserman AM, Krasnenkov DS, et al. Issledovanie dlinyi telomer u patsientov s boleznyu Parkinsona [Study of telomere length in patients with Parkinson's disease]. Zhurnal nevrologii i psihiatrii. 2014; 114(8): 59–62.
  9. Gadalla SM, Cawthon R, Giri N, et al. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging (Albany NY). 2010; 2(11): 867–874.
  10. Krasnenkov DS, Loseva DA, Kolyada AK, et al. Dlina telomer v bukkalnom epitelii u zhiteley raznogo vozrasta kievskoy oblasti [Telomere length in the buccal epithelium of the Kiev region residents of different ages]. Probl. Stareniya i Dolgoletiya. 2015; 24(2): 111–119.
  11. Kjeldsen SE, Aksnes TA, Ruilope LM. Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring. Drugs R D. 2014; 14(2): 31–43.
  12. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015; 38(1): 140–149.
  13. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37(3): e21.
  14. Weischer M, Bojesen SE, Cawthon RM, et al. Short telomere length, myocardial infarction, ischemic heart disease, and early death. Arterioscler Thromb Vasc Biol. 2012; 32(3): 822–829.
  15. Williams B, Mancia G, Spiering W, et al. Authors/Task Force Members:. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36(10): 1953–2041.
  16. Ermakova EA, Ametov AS, Chernikova NA. Saharnyiy diabet i arterialnaya gipertenziya [Diabetes mellitus and arterial hypertension]. Arterialnaya Gipertenziya. 2015; 12: 12–17.
  17. Esteghamati A, Eskandari D, Mirmiranpour H, et al. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clin Nutr. 2013; 32(2): 179–185.
  18. Lodovici M, Bigagli E, Luceri C, et al. Gender-related drug effect on several markers of oxidation stress in diabetes patients with and without complications. Eur J Pharmacol. 2015; 766: 86–90.
  19. Raschenberger J, Kollerits B, Titze S, et al. GCKD study Investigators. Do telomeres have a higher plasticity than thought? Results from the German Chronic Kidney Disease (GCKD) study as a high-risk population. Exp Gerontol. 2015; 72: 162–166.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl